Michael David Katz MD

Michael David Katz MD, listed as board member, appears in our data through filings on Hanover Bancorp, Inc. /MD shares, published by SEC (Form 4). Over a trading history stretching from 11 May 2022 to 5 February 2026, the count stands at 10 filings.

The open-market side counts 4 purchases for €113k alongside 1 sale for €121k. Taken together, the sales exceed the purchases by €8,158. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 4 share grants and 1 option exercise.

In size, the median ticket on the buying side is €6,206. Clusters matter here: 1 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 9 February 2026, reports a share grant in Hanover Bancorp, Inc. /MD. The latest purchase dates back some time: it was published 1,015 days ago, on 30 January 2024. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.